Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 4/2020

01.04.2020 | Original Article – Clinical Oncology

Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary

verfasst von: Won Ki Cho, Jong-Lyel Roh, Kyung-Ja Cho, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cervical metastasis from unknown primary (CUP) is commonly classified as an advanced overall stage. P16 or human papillomavirus (HPV) positivity in metastatic lymph nodes (LN) might be associated with a favorable survival outcome of CUP. Therefore, we evaluated the prognostic values of p16 immuno-positivity in LN and other clinicopathological factors in patients with squamous cell carcinoma CUP (SCCUP).

Methods

This study involved 83 patients who underwent therapeutic neck dissection and panendoscopic examination and biopsy for suspected CUP. P16 immunostaining and HPV typing in LN were performed in 56 patients. Cox proportional hazard regression analyses were used to identify factors associated with overall survival (OS) and disease-free survival (DFS).

Results

Postoperatively, primary tumors (PT) were found in 32 (38.6%) patients, mainly (90.6%) in the oropharynx, and not found in 51 (61.4%) patients. The clinicopathological data (except for histological grade) and 5-year OS and DFS rates did not significantly differ between patients with and without PT identification (all P > 0.05). P16 positivity was associated with favorable OS and DFS outcomes in the patients with PT (P < 0.05) but not in those without PT (P > 0.1). Multivariate analyses showed that age (> 60 years) and LN ratio (≥ 0.1) were the independent predictors of OS and DFS outcomes (all P < 0.05). P16 positivity or other factors were not independent factors.

Conclusion

Age and LN ratio are significant risk factors of survival and recurrence after primary surgery for SCCUP. Prognostic significance of LN p16 positivity should be further studied.
Literatur
Zurück zum Zitat Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRef Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRef
Zurück zum Zitat Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH (2003) Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9(17):6469–6475PubMed Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH (2003) Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9(17):6469–6475PubMed
Zurück zum Zitat Boscolo-Rizzo P, Schroeder L, Romeo S, Pawlita M (2015) The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review. Clin Exp Metastasis 32(8):835–845CrossRef Boscolo-Rizzo P, Schroeder L, Romeo S, Pawlita M (2015) The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review. Clin Exp Metastasis 32(8):835–845CrossRef
Zurück zum Zitat Denaro N, Merlano MC, Russi EG (2016) Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol 9(4):287–297CrossRef Denaro N, Merlano MC, Russi EG (2016) Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol 9(4):287–297CrossRef
Zurück zum Zitat Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, Shah JL, Hara W (2016) Lymph node count From neck dissection predicts mortality in head and neck cancer. J Clin Oncol 34(32):3892–3897CrossRef Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, Shah JL, Hara W (2016) Lymph node count From neck dissection predicts mortality in head and neck cancer. J Clin Oncol 34(32):3892–3897CrossRef
Zurück zum Zitat Dixon PR, Au M, Hosni A, Perez-Ordonez B, Weinreb I, Xu W, Song Y, Huang SH, O'Sullivan B, Goldstein DP, de Almeida JR (2016) Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma. Head Neck 38(9):1347–1353CrossRef Dixon PR, Au M, Hosni A, Perez-Ordonez B, Weinreb I, Xu W, Song Y, Huang SH, O'Sullivan B, Goldstein DP, de Almeida JR (2016) Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma. Head Neck 38(9):1347–1353CrossRef
Zurück zum Zitat D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944–1956CrossRef D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944–1956CrossRef
Zurück zum Zitat Dunne AA, Muller HH, Eisele DW, Kessel K, Moll R, Werner JA (2006) Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer 42(12):1863–1868CrossRef Dunne AA, Muller HH, Eisele DW, Kessel K, Moll R, Werner JA (2006) Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer 42(12):1863–1868CrossRef
Zurück zum Zitat Galloway TJ, Ridge JA (2015) Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol 33(29):3328–3337CrossRef Galloway TJ, Ridge JA (2015) Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol 33(29):3328–3337CrossRef
Zurück zum Zitat Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337–344CrossRef Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337–344CrossRef
Zurück zum Zitat Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Van Eyk JE, Zumsteg ZS (2017) Metastatic lymph node burden and survival in oral cavity cancer. J Clin Oncol 35(31):3601–3609CrossRef Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Van Eyk JE, Zumsteg ZS (2017) Metastatic lymph node burden and survival in oral cavity cancer. J Clin Oncol 35(31):3601–3609CrossRef
Zurück zum Zitat Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS (2018) Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer. JAMA Oncol 4(7):985–989CrossRef Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS (2018) Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer. JAMA Oncol 4(7):985–989CrossRef
Zurück zum Zitat Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS (2002) Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 112(11):2009–2014CrossRef Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS (2002) Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 112(11):2009–2014CrossRef
Zurück zum Zitat Joo YH, Cho JK, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS (2019) Guidelines for the surgical management of oral cancer: Korean society of thyroid-head and neck surgery. Clin Exp Otorhinolaryngol 12(2):107–144CrossRef Joo YH, Cho JK, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS (2019) Guidelines for the surgical management of oral cancer: Korean society of thyroid-head and neck surgery. Clin Exp Otorhinolaryngol 12(2):107–144CrossRef
Zurück zum Zitat Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA (2014) p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head Neck 36(12):1677–1684CrossRef Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA (2014) p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head Neck 36(12):1677–1684CrossRef
Zurück zum Zitat Kim SY, Nam SY, Choi SH, Cho KJ, Roh JL (2011) Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann Surg Oncol 18(8):2310–2317CrossRef Kim SY, Nam SY, Choi SH, Cho KJ, Roh JL (2011) Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma. Ann Surg Oncol 18(8):2310–2317CrossRef
Zurück zum Zitat Kim BH, Park SJ, Jeong WJ, Ahn SH (2018) Comparison of treatment outcomes for T3 glottic squamous cell carcinoma: a meta-analysis. Clin Exp Otorhinolaryngol 11(1):1–8CrossRef Kim BH, Park SJ, Jeong WJ, Ahn SH (2018) Comparison of treatment outcomes for T3 glottic squamous cell carcinoma: a meta-analysis. Clin Exp Otorhinolaryngol 11(1):1–8CrossRef
Zurück zum Zitat Koch WM, Bhatti N, Williams MF, Eisele DW (2001) Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 124(3):331–333CrossRef Koch WM, Bhatti N, Williams MF, Eisele DW (2001) Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 124(3):331–333CrossRef
Zurück zum Zitat Kwon M, Roh JL, Lee J, Cho KJ, Choi SH, Nam SY, Kim SY (2015) Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. J Craniomaxillofac Surg 43(6):769–778CrossRef Kwon M, Roh JL, Lee J, Cho KJ, Choi SH, Nam SY, Kim SY (2015) Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. J Craniomaxillofac Surg 43(6):769–778CrossRef
Zurück zum Zitat Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP (2017) Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122–137CrossRef Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP (2017) Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122–137CrossRef
Zurück zum Zitat Mermod M, Tolstonog G, Simon C, Monnier Y (2016) Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 62:60–71CrossRef Mermod M, Tolstonog G, Simon C, Monnier Y (2016) Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 62:60–71CrossRef
Zurück zum Zitat Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA (2008) Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30(1):28–34CrossRef Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA (2008) Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 30(1):28–34CrossRef
Zurück zum Zitat Mintzer DM, Warhol M, Martin AM, Greene G (2004) Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell cancer center of pennsylvania hospital. Oncologist 9(3):330–338CrossRef Mintzer DM, Warhol M, Martin AM, Greene G (2004) Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell cancer center of pennsylvania hospital. Oncologist 9(3):330–338CrossRef
Zurück zum Zitat Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344(15):1125–1131CrossRef Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344(15):1125–1131CrossRef
Zurück zum Zitat O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA (2012) Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 48(12):1191–1201CrossRef O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA (2012) Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 48(12):1191–1201CrossRef
Zurück zum Zitat Park GC, Lee M, Roh JL, Yu MS, Choi SH, Nam SY, Kim SY, Cho KJ (2012) Human papillomavirus and p16 detection in cervical lymph node metastases from an unknown primary tumor. Oral Oncol 48(12):1250–1256CrossRef Park GC, Lee M, Roh JL, Yu MS, Choi SH, Nam SY, Kim SY, Cho KJ (2012) Human papillomavirus and p16 detection in cervical lymph node metastases from an unknown primary tumor. Oral Oncol 48(12):1250–1256CrossRef
Zurück zum Zitat Park GC, Jung JH, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2014) Prognostic value of metastatic nodal volume and lymph node ratio in patients with cervical lymph node metastases from an unknown primary tumor. Oncology 86(3):170–176CrossRef Park GC, Jung JH, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2014) Prognostic value of metastatic nodal volume and lymph node ratio in patients with cervical lymph node metastases from an unknown primary tumor. Oncology 86(3):170–176CrossRef
Zurück zum Zitat Patel SG, L WM, Ridge CM, Mukherji SK, Ghossein RA, Brandwein-Gensler M (2017) In: Amin MB, Greene FL, Byrd DR, Brookland RK, Washington MK (eds) AJCC cancer staging manual, 8th edn. Springer, New York, pp 67–78CrossRef Patel SG, L WM, Ridge CM, Mukherji SK, Ghossein RA, Brandwein-Gensler M (2017) In: Amin MB, Greene FL, Byrd DR, Brookland RK, Washington MK (eds) AJCC cancer staging manual, 8th edn. Springer, New York, pp 67–78CrossRef
Zurück zum Zitat Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2009) Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 45(3):218–224CrossRef Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2009) Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 45(3):218–224CrossRef
Zurück zum Zitat Ross RB, Koyfman SA, Reddy CA, Houston N, Geiger JL, Woody NM, Joshi NP, Greskovich JF Jr, Burkey BB, Scharpf J, Lamarre ED, Prendes B, Lorenz RR, Adelstein DJ, Ward MC (2018) A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer. Laryngoscope 128(6):1379–1385CrossRef Ross RB, Koyfman SA, Reddy CA, Houston N, Geiger JL, Woody NM, Joshi NP, Greskovich JF Jr, Burkey BB, Scharpf J, Lamarre ED, Prendes B, Lorenz RR, Adelstein DJ, Ward MC (2018) A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer. Laryngoscope 128(6):1379–1385CrossRef
Zurück zum Zitat Schroeder L, Boscolo-Rizzo P, Dal Cin E, Romeo S, Baboci L, Dyckhoff G, Hess J, Lucena-Porcel C, Byl A, Becker N, Alemany L, Castellsague X, Quer M, Leon X, Wiesenfarth M, Pawlita M, Holzinger D (2017) Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: a retrospective multicentre study. Eur J Cancer 74:73–81CrossRef Schroeder L, Boscolo-Rizzo P, Dal Cin E, Romeo S, Baboci L, Dyckhoff G, Hess J, Lucena-Porcel C, Byl A, Becker N, Alemany L, Castellsague X, Quer M, Leon X, Wiesenfarth M, Pawlita M, Holzinger D (2017) Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: a retrospective multicentre study. Eur J Cancer 74:73–81CrossRef
Zurück zum Zitat Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D (2018) Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor. Int J Cancer 142(7):1361–1368CrossRef Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D (2018) Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor. Int J Cancer 142(7):1361–1368CrossRef
Zurück zum Zitat Sedghizadeh PP, Billington WD, Paxton D, Ebeed R, Mahabady S, Clark GT, Enciso R (2016) Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. Oral Oncol 54:15–27CrossRef Sedghizadeh PP, Billington WD, Paxton D, Ebeed R, Mahabady S, Clark GT, Enciso R (2016) Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. Oral Oncol 54:15–27CrossRef
Zurück zum Zitat Talmi YP, Takes RP, Alon EE, Nixon IJ, Lopez F, de Bree R, Rodrigo JP, Shaha AR, Halmos GB, Rinaldo A, Ferlito A (2018) Prognostic value of lymph node ratio in head and neck squamous cell carcinoma. Head Neck 40(5):1082–1090CrossRef Talmi YP, Takes RP, Alon EE, Nixon IJ, Lopez F, de Bree R, Rodrigo JP, Shaha AR, Halmos GB, Rinaldo A, Ferlito A (2018) Prognostic value of lymph node ratio in head and neck squamous cell carcinoma. Head Neck 40(5):1082–1090CrossRef
Zurück zum Zitat Tribius S, Hoffmann AS, Bastrop S, Gorogh T, Haag J, Rocken C, Clauditz T, Grob T, Wilczak W, Tennstedt P, Borcherding A, Petersen C, Hoffmann M (2012) HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. Oral Oncol 48(11):1178–1184CrossRef Tribius S, Hoffmann AS, Bastrop S, Gorogh T, Haag J, Rocken C, Clauditz T, Grob T, Wilczak W, Tennstedt P, Borcherding A, Petersen C, Hoffmann M (2012) HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. Oral Oncol 48(11):1178–1184CrossRef
Zurück zum Zitat Vatcheva KP, Lee M, McCormick JB, Rahbar MH (2016) Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology (Sunnyvale) 6(2):227CrossRef Vatcheva KP, Lee M, McCormick JB, Rahbar MH (2016) Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology (Sunnyvale) 6(2):227CrossRef
Zurück zum Zitat Yoo SH, Roh JL, Kim SO, Cho KJ, Choi SH, Nam SY, Kim SY (2015) Patterns and treatment of neck metastases in patients with salivary gland cancers. J Surg Oncol 111(8):1000–1006CrossRef Yoo SH, Roh JL, Kim SO, Cho KJ, Choi SH, Nam SY, Kim SY (2015) Patterns and treatment of neck metastases in patients with salivary gland cancers. J Surg Oncol 111(8):1000–1006CrossRef
Zurück zum Zitat Zhang MQ, El-Mofty SK, Davila RM (2008) Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer 114(2):118–123CrossRef Zhang MQ, El-Mofty SK, Davila RM (2008) Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer 114(2):118–123CrossRef
Zurück zum Zitat Zheng CM, Ji YB, Song CM, Ge MH, Tae K (2018) Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 11(1):58–64CrossRef Zheng CM, Ji YB, Song CM, Ge MH, Tae K (2018) Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 11(1):58–64CrossRef
Metadaten
Titel
Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary
verfasst von
Won Ki Cho
Jong-Lyel Roh
Kyung-Ja Cho
Seung-Ho Choi
Soon Yuhl Nam
Sang Yoon Kim
Publikationsdatum
01.04.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2020
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-03111-x

Weitere Artikel der Ausgabe 4/2020

Journal of Cancer Research and Clinical Oncology 4/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.